With downbeat sentiment having continued to prevail across the UK stock market in recent months, particularly in the small cap space, it...

Following on from a trading update in January, Bango released its preliminary numbers yesterday, which resulted in my once again catching...

It is over a year ago now since I last penned something on GETECH (GTC) , an AIM quoted business where I have an interest. So, following...

Last August, I took a look here at Diaceutics (DXRX), a provider of technology and analytical solutions serving the pharmaceutical and...

Around a year ago, I took a close look here on the blog at AIM quoted Frontier IP (FIPP) which invests in a portfolio of novel technology...

Anyone that took a punt on Filtronic (FTC)around the 11p mark last year will no doubt be decidedly happy today, given the recent solid...

It was just over a year ago that I first took a look here at TIME, the AIM quoted lender to small and medium sized businesses across the...

Well, we are just a few weeks into the New Year and on a personal level I am already experiencing some real ups and downs on the market....

Whilst the recruitment sector may not be to every investor’s liking, there are nevertheless some quality players on the market that can...

When it comes to identifying quality, well run operations on the AIM, stocks that receive a positive thumbs up on the box ticking front...

Concurrent Technologies has featured prominently here on the blog over the last six months, where I first highlighted it as being a...

As with many other investors, I like to keep a close eye out for potential recovery or turnaround plays, which if caught right, can...

Whilst market sentiment certainly doesn’t get any better, particularly across the smaller and micro-cap space, there nonetheless appears...

With the markets having been weak, particularly on the AIM, I haven’t exactly been surprised to see shares in AFM fall back in recent...

It was back in 2013 that I paid my first visit to Bango’s HQ in Cambridge, where on a cold and wet November afternoon I met up with...

It was back in January of this year that I penned my introductory piece on TIME Finance, the shares then standing at 22.5p which followed...

Concurrent Technologies released what were positive Interim Results this morning, with further confirmation of what is beginning to look...

Investing in the junior pharma/biotech sectors can be a risky business, with the occasional high rewards tempered more often than not...

Investing in pre-profitable growth stocks continues to be very much out of favour in these testing times, with once chunky valuations...

Although it was only last month that I covered Concurrent Technologies here and with the shares then sitting at 57p, subsequent news flow...